Your browser doesn't support javascript.
loading
The alterations of serum FGF-21 levels, metabolic and body composition in early breast cancer patients receiving adjuvant endocrine therapy.
Akyol, Murat; Alacacioglu, Ahmet; Demir, Leyla; Kucukzeybek, Yuksel; Yildiz, Yasar; Gumus, Zehra; Kara, Mete; Salman, Tarik; Varol, Umut; Taskaynatan, Halil; Oflazoglu, Utku; Bayoglu, Vedat; Tarhan, Mustafa Oktay.
Affiliation
  • Akyol M; Department of Medical Oncology, Manisa State Hospital, Manisa, Turkey.
  • Alacacioglu A; Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
  • Demir L; Department of Biochemistry, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
  • Kucukzeybek Y; Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
  • Yildiz Y; Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
  • Gumus Z; Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
  • Kara M; Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
  • Salman T; Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
  • Varol U; Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
  • Taskaynatan H; Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
  • Oflazoglu U; Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
  • Bayoglu V; Department of Medical Oncology, Izmir Katip Celebi University Ataturk Training and Research Hospital, Izmir, Turkey.
  • Tarhan MO; Institute of Oncology, Dokuz Eylul University, Izmir, Turkey.
Cancer Biomark ; 18(4): 441-449, 2017.
Article de En | MEDLINE | ID: mdl-28106545
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tamoxifène / Tumeurs du sein / Facteurs de croissance fibroblastique Type d'étude: Prognostic_studies Limites: Adult / Aged / Female / Humans / Middle aged Langue: En Journal: Cancer Biomark Sujet du journal: BIOQUIMICA / NEOPLASIAS Année: 2017 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Pays-Bas
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tamoxifène / Tumeurs du sein / Facteurs de croissance fibroblastique Type d'étude: Prognostic_studies Limites: Adult / Aged / Female / Humans / Middle aged Langue: En Journal: Cancer Biomark Sujet du journal: BIOQUIMICA / NEOPLASIAS Année: 2017 Type de document: Article Pays d'affiliation: Turquie Pays de publication: Pays-Bas